Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
At 50, focusing on the right investments is essential. Learn which options can help you achieve your retirement goals.
19,777 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
ServiceNow stands near $112 ahead of July 22 earnings, with a bullish setup built on rising subscription growth, soli...
Abbott Laboratories moved higher after boosting its profit outlook and signaling strength across its diagnostics and ...
When netflix stock fell this past week, investors looked beyond headline results to the quality of communication from...
MSCI stock is facing a sharp move lower after quarterly results and an strategic shift. This article explains the dri...
Accelerant Holdings has fallen sharply since its IPO, but a major fund just took a sizable stake. This article explai...
Broadcom sits at the crossroads of AI infrastructure and traditional networking. Here are three grounded predictions ...
Is Nebius the nebius next amazon? This article digs into Nebius's model, how it stacks up to Amazon, and what it woul...
Constellation Energy stock climbing today reflects a mix of solid quarterly results and favorable energy-market dynam...
The national debt sits just shy of $39 trillion, days before national debt crosses the milestone. Markets are watchin...
TeraWulf releases Q4 2025 results after the bell, signaling a shift from Bitcoin mining to AI compute. After-hours tr...
A sharp rally in Chime Financial shares followed stronger-than-expected Q4 guidance. This piece breaks down the drive...